Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.
Kim JH, Park HS, Heo SJ, Kim SK, Han JW, Shin KH, Kim SH, Hur H, Kim KS, Choi YD, Kim S, Lee YH, Suh JS, Ahn JB, Chung HC, Noh SH, Rha SY, Kim HS.
Kim JH, et al.
Oncology. 2019;96(2):59-69. doi: 10.1159/000492597. Epub 2018 Oct 18.
Oncology. 2019.
PMID: 30336470